BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Hass HG, Kreysel C, Fischinger J, Menzel J, Kaiser S. High-dose interferon-α2b induction therapy in combination with ribavirin for treatment of chronic hepatitis C in patients with non-response or relapse after interferon-α monotherapy. World J Gastroenterol 2005; 11(34): 5342-5346 [PMID: 16149143 DOI: 10.3748/wjg.v11.i34.5342]
URL: https://www.wjgnet.com/1007-9327/full/v11/i34/5342.htm
Number Citing Articles
1
C. Tural, R. Solà, R. Rubio, M. Santín, R. Planas, C. Quereda, J. Berenguer, M. Montes‐Ramírez, B. Clotet. Safety and efficacy of an induction dose of pegylated interferon alpha‐2a on early hepatitis C virus kinetics in HIV/HCV co‐infected patients: the CORAL‐1 multicentre pilot studyJournal of Viral Hepatitis 2007; 14(10): 704 doi: 10.1111/j.1365-2893.2007.00860.x
2
Ronald L Koretz, Maria Pleguezuelo, Vasiliki Arvaniti, Pilar Barrera Baena, Ruben Ciria, Kurinchi Selvan Gurusamy, Brian R Davidson, Andrew K Burroughs. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis CCochrane Database of Systematic Reviews 2013;  doi: 10.1002/14651858.CD003617.pub2
3
Catherine Carr, F. Blaine Hollinger, Boris Yoffe, Adil Wakil, Jason Phillips, Natalie Bzowej, Janet Leung, Katherine Mirro, Fred Poordad, Dan H. Moore, Robert G. Gish. Efficacy of interferon alpha‐2b induction therapy before retreatment for chronic hepatitis CLiver International 2007; 27(8): 1111 doi: 10.1111/j.1478-3231.2007.01535.x